CSRP3 and cardiac hypertrophy: Previous studies indicate that Grx3, especially the C‐terminal region of Grx3, can physically interact with a muscle LIM protein (MLP) to prevent the formation of the MLP–calcineurin complex, and thus blocking calcineurin–NFAT signaling associated with the development of cardiac hypertrophy under pressure overload (Jeong et al.